Harmony Biosciences Holdings

Harmony Biosciences Holdings

HRMY· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +8.7% in FY2025

Jeffrey Dayno is the CEO of Harmony Biosciences Holdings and was paid $7.9M in FY2025 (Dec), up 11%.

Pay$100 in the stock at the end of FY22 → $68
CEO pay is from each Harmony Biosciences Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives6

See all
  1. 1Jeffrey DaynoFY2025
  2. 2Adam ZaeskeFY2025
  3. 3Sandip KapadiaFY2025
  4. 4Jeffrey DierksFY2025
  5. 5Kumar BudurFY2025
  6. 6Andrew SerafinFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Harmony Biosciences Holdings paid its 6 named executives $21.4M in total in FY2025 (Dec). CEO Jeffrey Dayno was paid $7.9M of that.

Name
Jeffrey DaynoPresident and Chief Executive Officer
Adam ZaeskeEVP and Chief Commercial OfficerNot disclosedNot disclosed
Sandip KapadiaEVP and Chief Financial Officer and Chief Administrative Officer
Jeffrey DierksFormer EVP and Chief Commercial OfficerNot disclosed
Kumar BudurEVP and Chief Medical & Scientific Officer
Andrew SerafinEVP, Chief Strategy Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers13

See all

The FY2025 (Dec) proxy of Harmony Biosciences Holdings names 13 peer companies for pay. Among Harmony Biosciences Holdings and these peers, CEO pay was 3rd highest of 4 and total shareholder return was the lowest of 4.

3rd highest of 4in Harmony Biosciences Holdings and its pay peers, FY2025 (Dec) by CEO pay:

$6.9M$24.3M

4th highest of 4in Harmony Biosciences Holdings and its pay peers, FY2025 (Dec) by total shareholder return:

$104$245

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Activity

  1. Pay
    Harmony Biosciences Holdings CFO pay rose 480% to $5.6M. The stock fell 41% in FY2023 (Dec).
    DEF 14A
  2. Pay
    Harmony Biosciences Holdings Division head pay fell 60% to $2.3M. The stock rose 9% in FY2025 (Dec).
    DEF 14A
  3. Pay
    Harmony Biosciences Holdings CEO pay rose 11% to $7.9M. The stock rose 9% in FY2025 (Dec).
    DEF 14A
  4. Pay
    Harmony Biosciences Holdings CFO pay fell 45% to $3.1M. The stock rose 7% in FY2024 (Dec).
    DEF 14A
  5. Pay
    Harmony Biosciences Holdings CFO pay fell 85% to $962.6K. The stock rose 29% in FY2022 (Dec).
    DEF 14A
  6. Pay
    Harmony Biosciences Holdings Division head pay rose 653% to $5.7M. The stock rose 7% in FY2024 (Dec).
    DEF 14A
  7. Pay
    Harmony Biosciences Holdings CEO pay rose 61% to $7.1M. The stock rose 7% in FY2024 (Dec).
    DEF 14A
  8. Pay
    Harmony Biosciences Holdings EVP, Chief Strategy Officer pay rose 222% to $2.1M. The stock rose 7% in FY2024 (Dec).
    DEF 14A
  9. Pay
    Harmony Biosciences Holdings President pay fell 93% to $36.6K. The stock fell 41% in FY2023 (Dec).
    DEF 14A
  10. Pay
    Harmony Biosciences Holdings President pay fell 42% to $514.8K. The stock rose 29% in FY2022 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AApr 3, 2026FY2025
Annual report10-KFeb 24, 2026FY2025
Proxy statementDEF 14AApr 4, 2025FY2024
Annual report10-KFeb 25, 2025FY2024
Proxy statementDEF 14AApr 11, 2024FY2023
Annual report10-KFeb 22, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data